A Study of Radiotherapy Planning System Software ---- Zeus Cloud

Sun Yat-sen University63 enrolled

Overview

To evaluate the feasibility of Zeus Cloud TPS in the design of photon intensity modulated radiation therapy (IMRT) plan for tumors in various parts of the body.

This is a self-control, multi-center non-inferiority study. Subjects meeting inclusion criteria have radiation treatment plans designed by Zeus Cloud TPS and Eclipse treatment planning software from Varian, respectively. The qualities of two plans are compared. This is a observational study as the two plans are not executed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Radiotherapy

Interventions

Zeus Cloud TPS V1.0OTHER

Zeus Cloud TPS V1.0 is used to design the radiotherapy plan for the subjects and the plan is evaluated.

EclipseOTHER

Eclipse TPS of Varian company is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with confirmed brain glioma, nasopharyngeal carcinoma, lung cancer, esophageal cancer, gastric cancer, liver cancer, prostate cancer, cervical cancer and rectal cancer; 2. The medical imaging data (CT) of the subjects were complete and available; 3. Between 18 and 75 years old, regardless of gender; Exclusion Criteria: 1. The patients had metal implants; 2. Not suitable for clinical trials judged by investigators.

Outcomes

Primary Outcomes

The qualification rate of treatment plans based on dosimetry

Time frame: 2 months

Secondary Outcomes

The conformability index of radiation dose to the target

Time frame: 2 months

single-field pass rate

Time frame: 2 months

composite-field pass rate

Time frame: 2 months

Central Contacts

Bo Qiu, MD

CONTACT

+86-020-87343031 qiubo@sysucc.org.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.